A growing number of patients and family members are reporting Onglyza complications and even death linked with the popular diabetes medication. Some have begun filing lawsuits against the drug manufacturer over these Onglyza complications, alleging that they were not adequately warned of the risks.

If you or someone you love has suffered from Onglyza complications or even died after using this medication, you may be able to pursue litigation.

Background of Onglyza

Onglyza, also known by its generic name, saxagliptin, is a popular diabetes treatment. Saxagliptin is also combined with metformin hydrochloride and is marketed as Kombiglyze XR.

Onglyza is manufactured by pharmaceutical giants AstraZeneca and Bristol-Myers Squibb. Onglyza was first approved by the U.S. Food and Drug Administration (FDA) back in 2009. Kombiglyze XR was approved just a year later, in 2010.

Since its release onto the market, the popularity of Onglyza has steadily increased. In fact, sales of this diabetes drug are projected to reach $2 billion annually in the near future.

Despite their popularity, these drugs have been linked with serious complications, including heart failure. Indeed, a recent study shows a link between these diabetes drugs and an increased incidence of hospitalization for heart failure.

Background of Onglyza

Onglyza was created to treat type-2 diabetes and belongs to a class of similar drugs known as incretin mimetics. Incretin mimetics are made to mimic the body’s natural incretin hormones, which stimulate insulin releasing after a meal. This helps to control the blood sugar level of a diabetes patient.

Incretin mimetics are a relatively new class of diabetes drugs, one that rose quickly in popularity after the drug Avandia was recalled due to cardiac death risk.

Unfortunately, Onglyza has been linked with a number of serious Onglyza complications, including heart side effects like heart failure.

Onglyza Complications

Indeed, even a study funded by the manufacturers of the drug found that patients who used saxagliptin faced a higher rate of heart failure-related hospitalizations. The study was published in the New England Journal of Medicine in 2013, and found that patients who took Onglyza were more likely to be hospitalized due to heart failure than those who took other medications.

Filing a Lawsuit Over Onglyza Complications

Patients who have taken Onglyza, or a similar incretin-based drug like Kombiglyze XR, have begun filing lawsuits against AstraZeneca and Bristol-Myers Squibb. These plaintiffs allege that the manufacturers failed to adequately warn both the public and the medical community about the risk of serious Onglyza complications like heart failure.

If you or someone you love has suffered or died from Onglzya risks like heart failure or other serious side effects, you may be able to take legal action. Filing an Onglyza lawsuit cannot take away the pain and suffering caused by Onglyza complications, but it can help to alleviate financial costs from medical expenses and lost wages.